Literature DB >> 26873955

Comment: Is 3,4-DAP a new option in treating MuSK MG?

Lisa D Hobson-Webb1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26873955     DOI: 10.1212/WNL.0000000000002475

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  1 in total

Review 1.  Muscle-Specific Receptor Tyrosine Kinase (MuSK) Myasthenia Gravis.

Authors:  Rebecca L Hurst; Clifton L Gooch
Journal:  Curr Neurol Neurosci Rep       Date:  2016-07       Impact factor: 5.081

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.